Atantares
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 6
About Atantares
, trading as Atantares, is a biotechnology company that develops molecular microarrays using integrated circuit technology to provide services such as high-throughput synthesis and detection of molecules such as DNA, RNA, and proteins. The company's team comes from MIT, Tsinghua University and other institutions, and Intel, Thermo Fisher and other technology companies, in biotechnology, integrated circuits, MEMS and microfluidics and other aspects of R & D capabilities and DNA synthesis services. The co-founder, Mr. Dan Wu, graduated from MIT Mechanical Department and has independently developed a POC immunoassay platform for detecting sepsis with high throughput and high sensitivity. The company utilizes integrated circuit technology to develop molecular chips for high-throughput synthesis and detection of molecules such as DNA, RNA, and proteins. Meanwhile, based on the downward extension of the DNA synthesis platform, the Company utilizes its synthesis process management system and automated instrument development capabilities to further expand into applications such as mRNA drug discovery and single-molecule detection. Among them, based on the high-throughput DNA synthesis technology, the company has completed the proof of principle and the prototype of desktop high-throughput DNA synthesizer, as well as providing primer synthesis, gene synthesis, subcloning, point mutation, strain library preparation and other services for biological companies and research institutes.
Who invested in Atantares
6 investors across 3 rounds
See all investors in Atantares
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atantares
Who invested in Atantares?
Atantares has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atantares raised?
Atantares has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Atantares last raise money?
Atantares's most recent round on record is a Series A, in Jan 2026.
What does Atantares do?
, trading as Atantares, is a biotechnology company that develops molecular microarrays using integrated circuit technology to provide services such as high-throughput synthesis and detection of molecules such as DNA, RNA, and proteins.
Where is Atantares headquartered?
Atantares is headquartered in Suzhou Industrial Park, China.
Which VCs invest in companies like Atantares?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Atantares's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Atantares? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.